"Risk Reduction Behavior" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.
| Descriptor ID |
D040242
|
| MeSH Number(s) |
F01.145.699
|
| Concept/Terms |
Risk Reduction Behavior- Risk Reduction Behavior
- Behavior, Risk Reduction
- Behaviors, Risk Reduction
- Risk Reduction Behaviors
- Lifestyle Risk Reduction
- Lifestyle Risk Reductions
|
Below are MeSH descriptors whose meaning is more general than "Risk Reduction Behavior".
Below are MeSH descriptors whose meaning is more specific than "Risk Reduction Behavior".
This graph shows the total number of publications written about "Risk Reduction Behavior" by people in this website by year, and whether "Risk Reduction Behavior" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 5 | 4 | 9 |
| 2009 | 0 | 2 | 2 |
| 2010 | 3 | 3 | 6 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 3 | 3 |
| 2014 | 6 | 4 | 10 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 3 | 5 |
| 2018 | 1 | 6 | 7 |
| 2019 | 4 | 2 | 6 |
| 2020 | 2 | 4 | 6 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Reduction Behavior" by people in Profiles.
-
Randomized Controlled Trial Based US Commercial Payor Cost-Effectiveness Analysis of Endoscopic Sleeve Gastroplasty Versus Lifestyle Modification Alone for Adults With Class I/II Obesity. Obes Surg. 2024 Sep; 34(9):3275-3284.
-
Optimal breast cancer risk reduction policies tailored to personal risk level. Health Care Manag Sci. 2022 Sep; 25(3):363-388.
-
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial. J Am Soc Nephrol. 2021 11; 32(11):2900-2911.
-
Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105914.
-
Using Intervention Mapping to Developmentally Adapt an Online HIV Risk Reduction Program for Adolescent Men Who Have Sex with Men. Prev Sci. 2020 10; 21(7):885-897.
-
Implementation of Systematic Community Resource Referrals at Small Primary Care Practices to Promote Cardiovascular Disease Self-Management. J Healthc Qual. 2020 Sep-Oct; 42(5):278-286.
-
Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. Gastroenterology. 2020 11; 159(5):1985-1987.e4.
-
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers? Gynecol Oncol. 2020 06; 157(3):706-710.
-
Does the MLB's collision at home plate rule change prevent concussion injuries in catchers? Phys Sportsmed. 2020 09; 48(3):354-357.
-
Optimizing lifestyle interventions in adult patients with comorbid asthma and obesity. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620906323.